He C, He H, Yang X, Xing H, Lyu S, Wu M
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025; 55(6):1343-1349.
PMID: 39990827
PMC: 11839364.
DOI: 10.12182/20241160101.
Uthayakumar B, Cappelletto N, Bragagnolo N, Chen A, Ma N, Perks W
J Cereb Blood Flow Metab. 2025; :271678X251314683.
PMID: 39862181
PMC: 11765303.
DOI: 10.1177/0271678X251314683.
Patel S, Porcari P, Coffee E, Kim N, Berishaj M, Peyear T
Sci Adv. 2024; 10(51):eadr2058.
PMID: 39705365
PMC: 11661454.
DOI: 10.1126/sciadv.adr2058.
Pigliapochi R, Peyear T, Ruan T, Keshari K
Anal Chem. 2024; .
PMID: 39034921
PMC: 11751133.
DOI: 10.1021/acs.analchem.4c02378.
Marin-Valencia I, Kocabas A, Rodriguez-Navas C, Miloushev V, Gonzalez-Rodriguez M, Lees H
Cell Metab. 2024; 36(6):1394-1410.e12.
PMID: 38838644
PMC: 11187753.
DOI: 10.1016/j.cmet.2024.05.002.
Hyperpolarized Carbon-13 Magnetic Resonance Imaging: Technical Considerations and Clinical Applications.
Lai Y, Hsieh C, Juan Y, Lu K, Lee H, Ng S
Korean J Radiol. 2024; 25(5):459-472.
PMID: 38685736
PMC: 11058429.
DOI: 10.3348/kjr.2024.0069.
Deuterium Metabolic Imaging Differentiates Glioblastoma Metabolic Subtypes and Detects Early Response to Chemoradiotherapy.
Low J, Cao J, Hesse F, Wright A, Tsyben A, Alshamleh I
Cancer Res. 2024; 84(12):1996-2008.
PMID: 38635885
PMC: 11176915.
DOI: 10.1158/0008-5472.CAN-23-2552.
Moving from conventional to adaptive risk stratification for oropharyngeal cancer.
Sandulache V, Kirby R, Lai S
Front Oncol. 2024; 14:1287010.
PMID: 38549938
PMC: 10972883.
DOI: 10.3389/fonc.2024.1287010.
Current methods for hyperpolarized [1-C]pyruvate MRI human studies.
Larson P, Bernard J, Bankson J, Bogh N, Bok R, Chen A
Magn Reson Med. 2024; 91(6):2204-2228.
PMID: 38441968
PMC: 10997462.
DOI: 10.1002/mrm.29875.
Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma.
Farah C, Mignion L, Jordan B
Int J Mol Sci. 2024; 25(3).
PMID: 38339003
PMC: 10855758.
DOI: 10.3390/ijms25031725.
Advanced Hyperpolarized C Metabolic Imaging Protocol for Patients with Gliomas: A Comprehensive Multimodal MRI Approach.
Autry A, Vaziri S, Gordon J, Chen H, Kim Y, Dang D
Cancers (Basel). 2024; 16(2).
PMID: 38254844
PMC: 10814348.
DOI: 10.3390/cancers16020354.
Evidence of C-lactate oxidation in the human brain from hyperpolarized C-MRI.
Uthayakumar B, Soliman H, Chen A, Bragagnolo N, Cappelletto N, Endre R
Magn Reson Med. 2024; 91(5):2162-2171.
PMID: 38230992
PMC: 11225103.
DOI: 10.1002/mrm.29919.
First in-human evaluation of [1-C]pyruvate in DO for hyperpolarized MRI of the brain: A safety and feasibility study.
Deh K, Zhang G, Park A, Cunningham C, Bragagnolo N, Lyashchenko S
Magn Reson Med. 2024; 91(6):2559-2567.
PMID: 38205934
PMC: 11009889.
DOI: 10.1002/mrm.30002.
New Horizons in Hyperpolarized C MRI.
Chaumeil M, Bankson J, Brindle K, Epstein S, Gallagher F, Grashei M
Mol Imaging Biol. 2023; 26(2):222-232.
PMID: 38147265
PMC: 10972948.
DOI: 10.1007/s11307-023-01888-5.
Dynamic relaxometry of hyperpolarized [1- C]pyruvate MRI in the human brain and kidneys.
Liu X, Cui D, Xu D, Bok R, Wang Z, Vigneron D
Magn Reson Med. 2023; 91(3):1030-1042.
PMID: 38013217
PMC: 10872504.
DOI: 10.1002/mrm.29942.
Delivering Robust Proton-Only Sensing of Hyperpolarized [1,2-C]-Pyruvate Using Broad-Spectral-Range Nuclear Magnetic Resonance Pulse Sequences.
Mandzhieva I, Adelabu I, Nantogma S, Chekmenev E, Theis T
ACS Sens. 2023; 8(11):4101-4110.
PMID: 37948125
PMC: 10883757.
DOI: 10.1021/acssensors.3c01296.
Mutual-information based optimal experimental design for hyperpolarized [Formula: see text]C-pyruvate MRI.
Jha P, Walker C, Mitchell D, Oden J, Schellingerhout D, Bankson J
Sci Rep. 2023; 13(1):18047.
PMID: 37872226
PMC: 10593962.
DOI: 10.1038/s41598-023-44958-y.
Deuterium metabolic imaging for 3D mapping of glucose metabolism in humans with central nervous system lesions at 3T.
Adamson P, Datta K, Watkins R, Recht L, Hurd R, Spielman D
Magn Reson Med. 2023; 91(1):39-50.
PMID: 37796151
PMC: 10841984.
DOI: 10.1002/mrm.29830.
A Framework for Predicting X-Nuclei Transmitter Gain Using H Signal.
Vaeggemose M, Schulte R, Hansen E, Miller J, Rasmussen C, Pilgrim-Morris J
Tomography. 2023; 9(5):1603-1616.
PMID: 37736981
PMC: 10514872.
DOI: 10.3390/tomography9050128.
Hyperpolarized Carbon 13 MRI: Clinical Applications and Future Directions in Oncology.
Deen S, Rooney C, Shinozaki A, McGing J, Grist J, Tyler D
Radiol Imaging Cancer. 2023; 5(5):e230005.
PMID: 37682052
PMC: 10546364.
DOI: 10.1148/rycan.230005.